Position in VKTX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$54,560,241
-$5,896,342 QoQ
Shares Held
1,676,713
-2.4% QoQ
Ownership
1.44%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in VKTX Over Time
Shares Held
Position Value (USD)
Derivatives in VKTX
reported options exposure · as of Dec 31, 2025CallValue
$4,868,912
CallShares
138,400
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026D. E. Shaw & Co., Inc. holds $4,371,472,260 across 180 Biotechnology names. VKTX ranks #20 (1.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INSM |
INSMED Inc
|
5,625,825 | $919,934,903 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,059,062 | $350,411,843 | |
| 3 | BBIO |
BridgeBio Pharma, Inc.
|
2,545,486 | $189,027,789 | |
| 4 | PCVX |
Vaxcyte, Inc.
|
2,865,318 | $166,503,628 | |
| 5 | EXEL |
Exelixis, Inc.
|
3,603,063 | $154,535,371 | |
| 6 | HALO |
Halozyme Therapeutics, Inc.
|
1,868,708 | $120,774,597 | |
| 7 | PTCT |
Ptc Therapeutics, Inc.
|
1,640,381 | $111,759,157 | |
| 8 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
248,960 | $111,170,598 |
All Filings in VKTX
Export CSV
32 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $54,560,241 | 1,676,713 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $60,456,583 | 1,718,493 | Shares | Defined | 2026-02-17 | |
| 2025-12-31 | $4,868,912 | 138,400 | Call | Defined | 2026-02-17 | |
| 2025-09-30 | $4,240,461 | 161,357 | Shares | Defined | 2025-11-14 | |
| 2025-09-30 | $3,637,152 | 138,400 | Call | Defined | 2025-11-14 | |
| 2025-06-30 | $622,750 | 23,500 | Call | Defined | 2025-08-14 | |
| 2025-06-30 | $5,445,034 | 205,473 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $7,879,999 | 326,294 | Shares | Defined | 2025-05-15 | |
| 2025-03-31 | $567,525 | 23,500 | Call | Defined | 2025-05-15 | |
| 2024-12-31 | $4,114,258 | 102,243 | Shares | Defined | 2025-02-14 | |
| 2024-12-31 | $2,152,840 | 53,500 | Call | Defined | 2025-02-14 | |
| 2024-09-30 | $3,387,085 | 53,500 | Call | Defined | 2024-11-14 | |
| 2024-09-30 | $28,898,482 | 456,460 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $3,445,650 | 65,000 | Put | Defined | 2024-08-14 | |
| 2024-06-30 | $27,856,860 | 525,502 | Shares | Defined | 2024-08-14 | |
| 2024-06-30 | $2,650,500 | 50,000 | Call | Defined | 2024-08-14 | |
| 2024-03-31 | $4,100,000 | 50,000 | Call | Defined | 2024-05-15 | |
| 2024-03-31 | $6,210,844 | 75,742 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $2,151,967 | 115,635 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $951,797 | 85,980 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $5,364,245 | 330,922 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $14,153,414 | 850,055 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $8,941,656 | 951,240 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $37,715 | 13,866 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $49,997 | 17,300 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $528,834 | 176,278 | Shares | Defined | 2022-05-16 | |
| 2021-06-30 | $97,475 | 16,273 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $121,686 | 19,239 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $139,426 | 24,765 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $344,875 | 59,257 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $537,267 | 74,517 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $331,334 | 70,798 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||